Document is current
Any future updates will be listed below
-
Authors
Ikewaki, Nobunao
Rao, Kosagi-Sharaf
Archibold, Armando Durant
Iwasaki, Masaru
Senthilkumar, Rajappa
Preethy, Senthilkumar
Katoh, Shojiro
Abraham, Samuel J. K. http://orcid.org/0000-0003-2646-2687
- License Information
-
More Information
Article History
Received: 22 July 2020
Accepted: 22 September 2020
First Online: 16 October 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: 1. Nobunao Ikewaki is an employee of Dept. of Medical Life Science, Kyushu University of Health and Welfare, Japan & Institute of Immunology, Junsei Educational Institute, Nobeoka, Miyazaki, Japan2. Rao Kosagi-Sharaf and Armando Durant Archibold are employees of INDICASAT AIP, Panama3. Masaru Iwasaki is a faculty in Yamanashi University, Japan4. Rajappa Senthilkumar and Senthilkumar Preethy are employees of NCRM, India5. Shojiro Katoh is a faculty of EELS & employee of Edogawa Hospital, Japan6. Samuel Abraham is a faculty in Yamanashi University, EELS, Edogawa Hospital, Japan & NCRM, India, as well as shareholder in GN Corporation, Japan which in turn is a shareholder in the manufacturing company of the AFO 202 Beta Glucan.
